Literature DB >> 10784605

Regulatory role of mature B cells in a murine model of inflammatory bowel disease.

E Mizoguchi1, A Mizoguchi, F I Preffer, A K Bhan.   

Abstract

The spontaneous chronic colitis in TCR alpha mutant (TCRalpha(-/-)) mice mediated by CD4(+) TCRalpha(-)beta(+) T cells is more severe in the absence of mature B cells, suggesting a suppressive role of B cells and Ig in the development of chronic colitis. To investigate the direct role of B cells in the suppression of this colitis, cell transfer studies were performed in TCRalpha(-/-) x Igmu(-/-) (alphamu(-/-)) double-knockout mice. The chronic colitis was markedly attenuated in alphamu(-/-) mice after the adoptive transfer of peripheral B cells from TCRalpha(-/-) mice into 3- to 4-week-old alphamu(-/-) mice prior to the development of colitis. Furthermore, transfer of mature B cells from TCRalpha(-/-) mice markedly decreased the number of pathogenic colonic CD4(+) TCRalpha(-)beta(+) T cells in alphamu(-/-) mice with established colitis. This B cell effect required the presence of functional co-stimulatory molecules CD40 and B7-2 (CD86) but not B7-1 (CD80). These results indicate that mature B cells play an important role in the development of chronic colitis in TCRalpha(-/-) mice by directly regulating the pathogenic T cells (CD4(+) TCRalpha(-)beta(+) T cells).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784605     DOI: 10.1093/intimm/12.5.597

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  61 in total

1.  Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats.

Authors:  L A Dieleman; F Hoentjen; B-F Qian; D Sprengers; E Tjwa; M F Torres; C D Torrice; R B Sartor; S L Tonkonogy
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 2.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

3.  Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.

Authors:  Girdhari Lal; Yumi Nakayama; Apoorva Sethi; Amit K Singh; Bryna E Burrell; Neeraja Kulkarni; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Jonathan S Bromberg
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

Review 4.  The role of mucosal T lymphocytes in regulating intestinal inflammation.

Authors:  Holm H Uhlig; Fiona Powrie
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

5.  IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model.

Authors:  Koichi Yanaba; Ayumi Yoshizaki; Yoshihide Asano; Takafumi Kadono; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 6.  Inflammatory bowel disease, past, present and future: lessons from animal models.

Authors:  Atsushi Mizoguchi; Emiko Mizoguchi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

7.  Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice.

Authors:  Damian Maseda; Kathleen M Candando; Susan H Smith; Ioannis Kalampokis; Casey T Weaver; Scott E Plevy; Jonathan C Poe; Thomas F Tedder
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

Review 8.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies.

Authors:  Iurii Koboziev; Fridrik Karlsson; Songlin Zhang; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2011-02-10       Impact factor: 5.325

Review 9.  Innate response activator B cells: origins and functions.

Authors:  Benjamin G Chousterman; Filip K Swirski
Journal:  Int Immunol       Date:  2015-05-08       Impact factor: 4.823

Review 10.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.